Outset Medical, Inc. (OM) Dividend History

Company News

• Outset Medical to Present at RBC Global Healthcare Conference

  Outset Medical, a medical technology company, announced that members of its management team will participate in the RBC Capital Markets Global Health Care conference on May 20, 2025. The company's Tablo Hemodialysis System, which is FDA-cleared for use from the hospital to the home, represents a significant technological advancement in the dialysis industry.

  GlobeNewswire Inc.
• Outset Medical: Profitability Path Brightens

  Outset Medical reported strong Q4 earnings, with revenue and adjusted EPS beating analyst estimates. The company saw improved gross margins and reduced operating expenses, signaling progress towards profitability. Outset remains optimistic about future growth, projecting revenue of $115-$125 million by 2025.

  The Motley Fool
• This Nike Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday

  Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Oppenheimer analyst Brian Nagel upgraded the rating for NIKE, Inc. (NYSE:NKE) from Perform to Outperform, while raising the price target from $110 to $120. Nike shares gained 0.8% to close at $95.57 on Thursday. See how other analysts view this stock. Morgan Stanley analyst Carlos De Alba upgraded Alcoa Corporation (NYSE:AA) from Equal-Weight to Overweight and boosted the price target from $36.5 to $50. Alcoa shares ...Full story available on Benzinga.com

  Benzinga

  Featured Companies: AA FCX NKE PBH
• Outset Medical (OM) Upgraded to Buy: What Does It Mean for the Stock?

  Outset Medical (OM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

  Zacks Investment Research